inotuzumab ozogamicin
heteroclitic
-mul-
pancytokeratin
panitumumab
brentuximab
-bac-
bezlotoxumab
naptumomab estafenatox
bococizumab
amlitelimab
drozitumab
countercorrelated
immunomolecule
guselkumab
immunogen
-ab
atezolizumab
chromobody
glembatumumab
benralizumab
Duffy antigen
antimonoclonal
mapatumumab
karyoplasm
ozogamicin
patritumab
antiantibody
antisynthetase
bispecific
elotuzumab
tucotuzumab
sonepcizumab
dalotuzumab
immunoreactant
agonistic monoclonal antibody
ipilimumab
adebrelimab
milatuzumab
cibisatamab
duligotuzumab
apolizumab
bivatuzumab
immunoprobe
nu body
inotuzumab
lucatumumab
antihuman
volociximab
lorvotuzumab